KCCI Investigates spoke to seven nurses who have worked for MercyOne in the last year. They all brought up similar concerns about patient safety.

SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound ...

Organogenesis (NASDAQ: ORGO) Q3 2024 Earnings Call Nov 12, 2024, 5:00 p.m. ET ...

The Trump administration is expected to liberalise research into psychedelic-assisted therapies – and Emyria investors have ...

Since the 1991 Harvard Medical Practice Study revealed the extent of unintended injuries caused by medical care, there have been transformative changes in surgical care, such as increased use of ...

Nov. 12, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product ...

FB Dermatology’s products include: LumiHeal ®, which has a European Union MDR CE Mark for the treatment of chronic wounds, as well as a Class II de novo device (US Food and Drug Administration (FDA)) ...

Pavena Foundation for Children and Women—a local non-government organization that provides assistance to victims of abuse and harassment—shared that a 36-year-old woman from Narathiwat, Thailand ...

The results in patients with long, complex lesions are better than or equal to those of surgery, but without the ...

The Global Surgical Stapling Device Market is projected to be valued at US$ 3,977.40 million in 2023, with an anticipated growth trajectory reaching US$ 5,930.60 million by 2033. The market is ...

The collaboration between the two will assess the potential of SolasCure’s Aurase wound gel in combat situations using ...